Human T-cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada.
Sheila F O'BrienQi-Long YiMindy GoldmanYves GrégoireGilles DelagePublished in: Vox sanguinis (2018)
With universal leucoreduction in place, switching from universal testing to testing first-time donors would incur very low risk.
Keyphrases